1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown PrimaryCancer of Unknown PrimaryNot yet recruitingPhase 22025-03-12NCT06869174